Cleveland Diagnostics

Delfi Diagnostics

This company develops blood-based liquid biopsy tests for early cancer detection and treatment monitoring for healthcare providers, health systems, and biopharmaceutical partners.

Epiliquid

This company develops blood-based liquid biopsy tests for early cancer detection and monitoring, serving clinical laboratories and medical practitioners.

20/20 BioLabs

This company develops AI-powered blood tests for the early detection and prevention of cancers and chronic diseases for individuals and healthcare providers.

Infiniplex

This company develops liquid biopsy solutions using blood tests to monitor genetic biomarkers for cancer screening and precision oncology decisions for healthcare providers.

Glycanostics

This digital health company develops non-invasive liquid biopsy tests for early-stage cancer detection, serving clinical laboratories, hospitals and oncology professionals.

Foresight Diagnostics

This company develops liquid biopsy tests to detect minimal residual disease in cancer patients for biopharmaceutical companies and healthcare providers.

Fyr Bio

This company develops liquid biopsy diagnostic tools and biomarkers using extracellular vesicle enrichment technology for healthcare providers and pharmaceutical researchers.

Amadix

This company develops blood-based liquid biopsy tests for the early detection of colorectal, lung and pancreatic cancer in patients and healthcare settings.